At least 38 children have died from measles in Bangladesh as of March 30, 2026, with 32 of those deaths occurring in March alone, according to a correspondence published in The Lancet. The outbreak has struck with unusual severity, pushing paediatric wards to a breaking point. The Infectious Diseases Hospital in Mohakhali, Dhaka, admitted 560 suspected measles cases in the first quarter of 2026—a staggering increase from 69 cases for the entire previous year.
This resurgence exposes a critical immunisation emergency in a country that had made significant gains toward measles elimination. The Lancet authors describe the clinical pressure as "phenomenal," noting March accounted for 448 of those hospital admissions. Experts point to disruptions in routine vaccination campaigns during the COVID-19 pandemic as a likely underlying cause.
Before the outbreak, Bangladesh was on track to meet WHO targets for measles elimination. The sudden spike in mortality—with 32 deaths in a single month—suggests a deeper failure to maintain herd immunity. The case fatality rate among hospitalised children has not been specified but appears significantly elevated compared to historical norms.
If transmission continues unchecked, neighbouring countries with weaker health systems could face similar outbreaks. The Lancet authors call for immediate supplementary immunisation activities and stronger surveillance to prevent further loss of life. Scarce vaccine supplies and logistical barriers may hamper a rapid response.
Counter-argument: Some public health officials argue that single-season spikes do not necessarily indicate a systemic immunisation failure, and that data might reflect improved reporting rather than a true rise in mortality.